Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination?. Issue 2 (22nd January 2013)
- Record Type:
- Journal Article
- Title:
- Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination?. Issue 2 (22nd January 2013)
- Main Title:
- Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination?
- Authors:
- Winter, Rebecca J
Dietze, Paul M
Gouillou, Maelenn
Hellard, Margaret E
Robinson, Priscilla
Aitken, Campbell K - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="jgh12063-sec-0001" sec-type="section"> <title>Background and Aim</title> <p>Forty percent of new hepatitis B virus (HBV) infections in Australia occur in people who inject drugs (PWID); long‐term infection carries the risk of serious liver disease. HBV incidence among Australian PWID has not been measured since the advent of targeted (2001) and adolescent school‐based "catch‐up" (1998) vaccination programs. We measured HBV incidence and prevalence in a cohort of PWID in Melbourne, Australia and examined demographic and behavioral correlates of exposure and vaccination.</p> </sec> <sec id="jgh12063-sec-0002" sec-type="section"> <title>Methods</title> <p>Community‐recruited PWID were surveyed about blood‐borne virus risk behaviors and their sera tested for HBV markers approximately three‐monthly over three years. Incidence was assessed using prospectively collected data. A cross‐sectional design was used to examine prevalence of HBV exposure and vaccination at baseline. Poisson regression was used to identify correlates of HBV exposure and vaccination.</p> </sec> <sec id="jgh12063-sec-0003" sec-type="section"> <title>Results</title> <p>At baseline, 33.1% of participants (114/344) had been vaccinated against HBV, 40.4% (139/344) had been exposed (previously or currently infected), and 26.5% (91/344) were susceptible. HBV incidence was 15.7 per 100 person‐years. Independent associations with HBV exposure included<abstract abstract-type="main"> <title>Abstract</title> <sec id="jgh12063-sec-0001" sec-type="section"> <title>Background and Aim</title> <p>Forty percent of new hepatitis B virus (HBV) infections in Australia occur in people who inject drugs (PWID); long‐term infection carries the risk of serious liver disease. HBV incidence among Australian PWID has not been measured since the advent of targeted (2001) and adolescent school‐based "catch‐up" (1998) vaccination programs. We measured HBV incidence and prevalence in a cohort of PWID in Melbourne, Australia and examined demographic and behavioral correlates of exposure and vaccination.</p> </sec> <sec id="jgh12063-sec-0002" sec-type="section"> <title>Methods</title> <p>Community‐recruited PWID were surveyed about blood‐borne virus risk behaviors and their sera tested for HBV markers approximately three‐monthly over three years. Incidence was assessed using prospectively collected data. A cross‐sectional design was used to examine prevalence of HBV exposure and vaccination at baseline. Poisson regression was used to identify correlates of HBV exposure and vaccination.</p> </sec> <sec id="jgh12063-sec-0003" sec-type="section"> <title>Results</title> <p>At baseline, 33.1% of participants (114/344) had been vaccinated against HBV, 40.4% (139/344) had been exposed (previously or currently infected), and 26.5% (91/344) were susceptible. HBV incidence was 15.7 per 100 person‐years. Independent associations with HBV exposure included female gender, South‐East Asian ethnicity, drug treatment in the past three months, injecting in prison, and prior exposure to hepatitis C virus. Independent associations with vaccination included being ≤ 25 years old, reporting HBV vaccination, and never having been to prison.</p> </sec> <sec id="jgh12063-sec-0004" sec-type="section"> <title>Conclusions</title> <p>HBV infection continues at high incidence among Australian PWID despite the introduction of free vaccination programs. Innovative methods are needed to encourage PWID to complete HBV vaccination.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of gastroenterology and hepatology. Volume 28:Issue 2(2013:Feb.)
- Journal:
- Journal of gastroenterology and hepatology
- Issue:
- Volume 28:Issue 2(2013:Feb.)
- Issue Display:
- Volume 28, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 28
- Issue:
- 2
- Issue Sort Value:
- 2013-0028-0002-0000
- Page Start:
- 314
- Page End:
- 322
- Publication Date:
- 2013-01-22
- Subjects:
- Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Gastroenterology -- Periodicals
Liver Diseases -- Periodicals
616.33 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.blackwell-synergy.com/loi/jgh ↗ - DOI:
- 10.1111/jgh.12063 ↗
- Languages:
- English
- ISSNs:
- 0815-9319
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4987.615000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3417.xml